SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mkilloran who wrote (20311)4/6/1999 7:10:00 PM
From: VLAD  Read Replies (2) of 23519
 
*****NEWS*****

A lot going on in Europe regarding MUSE education to mds.

This Sat and Sun Vivus will be presenting lectures at the European Urological Association meeting concerning MUSE safety/efficacy/use instruction etc...

According to Vivus MUSE will be launched throughout the EU in May.

Vivus will be presenting 7 or 8 lectures at the American Association of Urologists meeting in Dallas in early May. Lectures will include the safety of MUSE in cardiac patients, the efficacy of MUSE on Viagra failures, gene therapy, and more.

Vivus will show a PROFIT for Q1 although as expected both international and domestic sales will be lower than in Q4 1998.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext